GSA Capital Partners LLP Cuts Stock Position in Clover Health Investments, Corp. (NASDAQ:CLOV)

GSA Capital Partners LLP trimmed its position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) by 60.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 359,392 shares of the company’s stock after selling 553,674 shares during the quarter. GSA Capital Partners LLP owned about 0.07% of Clover Health Investments worth $1,013,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of CLOV. Concurrent Investment Advisors LLC acquired a new stake in Clover Health Investments in the third quarter valued at approximately $28,000. Sigma Planning Corp acquired a new stake in shares of Clover Health Investments in the 3rd quarter worth $29,000. Viewpoint Capital Management LLC boosted its position in shares of Clover Health Investments by 96.8% in the 2nd quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company’s stock worth $38,000 after purchasing an additional 15,000 shares in the last quarter. Jaffetilchin Investment Partners LLC grew its stake in Clover Health Investments by 30.2% during the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock worth $39,000 after buying an additional 11,550 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC increased its position in Clover Health Investments by 54.4% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock valued at $42,000 after buying an additional 12,104 shares in the last quarter. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, UBS Group initiated coverage on Clover Health Investments in a report on Monday, October 7th. They issued a “neutral” rating and a $4.00 price target for the company.

Clover Health Investments Trading Down 1.3 %

Shares of Clover Health Investments stock opened at $3.04 on Friday. The firm’s 50 day simple moving average is $3.52 and its two-hundred day simple moving average is $2.26. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of -15.20 and a beta of 2.03. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.71.

Clover Health Investments (NASDAQ:CLOV) last released its earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.01. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. The firm had revenue of $330.99 million for the quarter, compared to the consensus estimate of $347.60 million. During the same period in the prior year, the firm earned ($0.09) EPS. On average, sell-side analysts predict that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.